Related references
Note: Only part of the references are listed.Genetic Modifiers and Rare Mendelian Disease
K. M. Tahsin Hassan Rahit et al.
GENES (2020)
Identification of AIDS-Associated Kaposi Sarcoma: A Functional Genomics Approach
Peng Zhang et al.
FRONTIERS IN GENETICS (2020)
Random walk with restart on multiplex and heterogeneous biological networks
Alberto Valdeolivas et al.
BIOINFORMATICS (2019)
Assembling systems biology, embryo development and teratogenesis: What do we know so far and where to go next?
Thayne Woycinck Kowalski et al.
REPRODUCTIVE TOXICOLOGY (2019)
Exploratory Gene Ontology Analysis with Interactive Visualization
Junjie Zhu et al.
SCIENTIFIC REPORTS (2019)
Identifying Cancer genes by combining two-rounds RWR based on multiple biological data
Wenxiang Zhang et al.
BMC BIOINFORMATICS (2019)
Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients
Viviana Tritto et al.
GENES (2019)
Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources
Sebastian Koehler et al.
NUCLEIC ACIDS RESEARCH (2019)
Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848
Magdalena Koczkowska et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency
Raphael Carapito et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
BAFfling pathologies: Alterations of BAF complexes in cancer
Ophelie Arnaud et al.
CANCER LETTERS (2018)
Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes
Parisa Sharafi et al.
JOURNAL OF NEUROGENETICS (2018)
Integrative gene ontology and network analysis of coronary artery disease associated genes suggests potential role of ErbB pathway gene EGFR
Madankumar Ghatge et al.
MOLECULAR MEDICINE REPORTS (2018)
Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome
Santhosh A. Upadhyaya et al.
PEDIATRIC BLOOD & CANCER (2018)
The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing
Fan Yang et al.
ONCOTARGETS AND THERAPY (2018)
Teratogen screening with human pluripotent stem cells
Kathryn E. Worley et al.
INTEGRATIVE BIOLOGY (2018)
Phenotype-oriented network analysis for discovering pharmacological effects of natural compounds
Sunyong Yoo et al.
SCIENTIFIC REPORTS (2018)
Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis
Yah-Huei Wu-Chou et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation
J. Wu et al.
ONCOGENE (2017)
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia
Richard J. L. Anney et al.
MOLECULAR AUTISM (2017)
SMARCB1/INI1 Loss in Epithelioid Schwannoma: A Clinicopathologic and Immunohistochemical Study of 65 Cases
Vickie Y. Jo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1
K. Wimmer et al.
CLINICAL GENETICS (2017)
Understanding the cancer cell phenotype beyond the limitations of current omics analyses
Rafael Moreno-Sanchez et al.
FEBS JOURNAL (2016)
Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity
Wissem Deraredj Nadim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomics
Maria Nicla Loviglio et al.
GENOME MEDICINE (2016)
Ten Simple Rules for Selecting a Bio-ontology
James Malone et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Quantitative and logic modelling of molecular and gene networks
Nicolas Le Novere
NATURE REVIEWS GENETICS (2015)
Prevalence of Autism Spectrum Disorder Symptoms in Children With Neurofibromatosis Type 1
Ellen Plasschaert et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2015)
The Cyclic AMP Pathway Is a Sex-Specific Modifier of Glioma Risk in Type I Neurofibromatosis Patients
Nicole M. Warrington et al.
CANCER RESEARCH (2015)
p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas
Valentina Pinna et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Genetic Modifiers of Neurofibromatosis Type 1-Associated Cafe-au-Lait Macule Count Identified Using Multi-platform Analysis
Alexander Pemov et al.
PLOS GENETICS (2014)
Germline PIK3CA and AKT1 Mutations in Cowden and Cowden-like Syndromes
Mohammed S. Orloff et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study
O. O. Seminog et al.
BRITISH JOURNAL OF CANCER (2013)
CXCR4/CXCL12 Mediate Autocrine Cell- Cycle Progression in NF1-Associated Malignant Peripheral Nerve Sheath Tumors
Wei Mo et al.
CELL (2013)
Novel Factors in the Pathogenesis of Psoriasis and Potential Drug Candidates Are Found with Systems Biology Approach
Mate Manczinger et al.
PLOS ONE (2013)
PTEN and NF1 Inactivation in Schwann Cells Produces a Severe Phenotype in the Peripheral Nervous System That Promotes the Development and Malignant Progression of Peripheral Nerve Sheath Tumors
Vincent W. Keng et al.
CANCER RESEARCH (2012)
MicroRNA-21 correlates with tumorigenesis in malignant peripheral nerve sheath tumor (MPNST) via programmed cell death protein 4 (PDCD4)
Satoru Itani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Neurofibromatosis type 1: from genotype to phenotype
Eric Pasmant et al.
JOURNAL OF MEDICAL GENETICS (2012)
MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors
Meng Gong et al.
NEURO-ONCOLOGY (2012)
LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators
Fabrizio Manetti
MEDICINAL RESEARCH REVIEWS (2012)
Variable Expression of Neurofibromatosis 1 in Monozygotic Twins
Margaret B. Rieley et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
The Akt signaling pathway An emerging therapeutic target in malignant melanoma
SubbaRao V. Madhunapantula et al.
CANCER BIOLOGY & THERAPY (2011)
Valosin-containing protein and neurofibromin interact to regulate dendritic spine density
Hsiao-Fang Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Another VCP interactor: NF is enough
Conrad C. Weihl
JOURNAL OF CLINICAL INVESTIGATION (2011)
Role of Noncoding RNA ANRIL in Genesis of Plexiform Neurofibromas in Neurofibromatosis Type 1
Eric Pasmant et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists
Jeanny H. Wang et al.
JOURNAL OF CANCER (2011)
SWI/SNF nucleosome remodellers and cancer
Boris G. Wilson et al.
NATURE REVIEWS CANCER (2011)
Birth Incidence and Prevalence of Tumor-Prone Syndromes: Estimates From a UK Family Genetic Register Service
D. G. Evans et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
Clinical and genetic aspects of neurofibromatosis 1
Kimberly Jett et al.
GENETICS IN MEDICINE (2010)
NF1 Microdeletions in Neurofibromatosis Type 1: From Genotype to Phenotype
Eric Pasmant et al.
HUMAN MUTATION (2010)
SPRED1 Mutations in a Neurofibromatosis Clinic
Talia M. Muram-Zborovski et al.
JOURNAL OF CHILD NEUROLOGY (2010)
Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions
V-F Mautner et al.
JOURNAL OF MEDICAL GENETICS (2010)
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours
Subbaya Subramanian et al.
JOURNAL OF PATHOLOGY (2010)
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Jane O. Johnson et al.
NEURON (2010)
From 'differential expression' to 'differential networking' - identification of dysfunctional regulatory networks in diseases
Alberto de la Fuente
TRENDS IN GENETICS (2010)
Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1
Audrey Sabbagh et al.
HUMAN MOLECULAR GENETICS (2009)
Germline BRAF Mutations in Noonan, LEOPARD, and Cardiofaciocutaneous Syndromes: Molecular Diversity and Associated Phenotypic Spectrum
Anna Sarkozy et al.
HUMAN MUTATION (2009)
PTEN dosage is essential for neurofibroma development and malignant transformation
Caroline Gregorian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
NF1 microduplication first clinical report: association with mild mental retardation, early onset of baldness and dental enamel hypoplasia?
Bernard Grisart et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype
Hilde Brems et al.
NATURE GENETICS (2007)
LIM kinases: function, regulation and association with human disease
Rebecca W. Scott et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
The importance of bottlenecks in protein networks: Correlation with gene essentiality and expression dynamics
Haiyuan Yu et al.
PLOS COMPUTATIONAL BIOLOGY (2007)
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation
M. Upadhyaya et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Neuro-fibromatosis 1 and neuro-fibromatosis 2: a twenty first century perspective
Rosalie E. Ferner
LANCET NEUROLOGY (2007)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
Connective tissue dysplasia in five new patients with NF1 microdeletions:: further expansion of phenotype and review of the literature -: art. no. e8
KA Mensink et al.
JOURNAL OF MEDICAL GENETICS (2006)
Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis
BC Ling et al.
CANCER CELL (2005)
The SWI/SNF complex - Chromatin and cancer
CWM Roberts et al.
NATURE REVIEWS CANCER (2004)
Intelligence in individuals with a neurofibromatosis type 1 microdeletion
MJ Descheemaeker et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Elevated risk for MPNST in NF1 microdeletion patients
T De Raedt et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1)
J Szudek et al.
GENETIC EPIDEMIOLOGY (2002)
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2002)
GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotype
M Bahuau et al.
JOURNAL OF MEDICAL GENETICS (2001)
Share Paper
